St. John's Wort (Hypericum perforatum): A Review of its Potential Antidepressant Efficacy and Safety
Mohsin Ahmed 1, Rownak Jahan 2, Mohammed Rahmatullah 2*
Australian Herbal Insight 4(1) 1-6 https://doi.org/10.25163/ahi.4110003
Submitted: 12 April 2021 Revised: 18 June 2021 Published: 19 June 2021
Abstract
Background: St. John's Wort (SJW), scientifically known as Hypericum perforatum, is widely utilized as an over-the-counter remedy for various ailments, particularly depression, despite lacking FDA approval. The active compounds in SJW, including hypericin, hyperforin, and flavonoids, are believed to alleviate depressive symptoms by inhibiting neurotransmitter reuptake. However, concerns regarding its safety arise from extensive drug-drug interactions, pointing to deficiencies in quality control and regulation of SJW distribution. Methods: This narrative review synthesizes existing literature on the therapeutic effects, safety profile, indications, and adverse effects of SJW in treating depression. It also examines the regulatory landscape surrounding SJW and highlights the necessity for standardized practices and comprehensive clinical trials. Results: SJW has shown efficacy in managing mild to moderate depression, with some studies suggesting it may offer benefits comparable to conventional antidepressants while exhibiting a more favorable side effect profile. However, significant safety concerns persist due to potential interactions with other medications, leading to adverse reactions such as serotonin syndrome. Current regulatory frameworks vary globally, with SJW classified as a dietary supplement in the U.S. and subjected to stricter regulations in Europe. Conclusion: Despite its widespread use and potential therapeutic benefits, the safety and efficacy of SJW in treating depression remain inadequately substantiated by clinical evidence. Enhanced regulatory measures and rigorous clinical research are imperative to clarify SJW's role in depression treatment and ensure its safe application in clinical practice. Inclusion in pharmacopeias and adherence to good manufacturing practices could further improve the quality and safety of SJW products.
Keywords: St. John's Wort, Hypericums, Hypericum perforatum, Johnswort, Emotional Depression, Major Depressive Disorder.
References
Ahmet Yildirim, Aksoy, T., Hüsniye Kayalar, & Ibrahim Cüneyt Balcioglu. (2024). Semen Cannabis and Oleum Hyperici: Antileishmanial activity against Leishmania tropica promastigotes and intracellular amastigotes. Parasitology International, 103, 102950–102950. https://doi.org/10.1016/j.parint.2024.102950
Allaire, A. (2000). Complementary and alternative medicine in pregnancy: a survey of North Carolina certified nurse-midwives. Obstetrics & Gynecology, 95(1), 19–23. https://doi.org/10.1016/s0029-7844(99)00481-0
Benitez, J. S. C., Hernandez, T. E., Sundararajan, R., Sarwar, S., Arriaga, A. J., Khan, A. T., Matayoshi, A., Quintanilla, H. A., Kochhar, H., Alam, M., Mago, A., Hans, A., & Benitez, G. A. (2022). Advantages and Disadvantages of Using St. John’s Wort as a Treatment for Depression. Cureus, 14(9). https://doi.org/10.7759/cureus.29468
Bladt, S., & Wagner, H. (1994). Inhibition of MAO by Fractions and Constituents of Hypericum Extract. Journal of Geriatric Psychiatry and Neurology, 7(1), 57–59. https://doi.org/10.1177/089198879400700115
Butterweck, V. (2003). Mechanism of Action of St John’s Wort in Depression. CNS Drugs, 17(8), 539–562. https://doi.org/10.2165/00023210-200317080-00001
Caccia, S., & Gobbi, M. (2009). St. Johns Wort Components and the Brain: Uptake, Concentrations Reached and the Mechanisms Underlying Pharmacological Effects. Current Drug Metabolism, 10(9), 1055–1065. https://doi.org/10.2174/138920009790711878
Chakraborty, S., Piyush Baindara, Sharma, P., Austin Jose T, Kumaravel V, Manoharan, R., & Mandal, S. M. (2024). Anti-Biofilm Action of Cineole and Hypericum perforatum to Combat Pneumonia-Causing Drug-Resistant P. aeruginosa. Antibiotics, 13(8), 689–689. https://doi.org/10.3390/antibiotics13080689
Chand, S., & Arif, H. (2023, July 17). Depression. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430847/
Dennehy, C., Tsourounis, C., Bui, L., & King, T. L. (2010). The Use of Herbs by California Midwives. Journal of Obstetric, Gynecologic & Neonatal Nursing, 39(6), 684–693. https://doi.org/10.1111/j.1552-6909.2010.01193.x
Di Carlo, G., Borrelli, F., Ernst, E., & Izzo, A. A. (2001). St John’s wort: Prozac from the plant kingdom. Trends in Pharmacological Sciences, 22(6), 292–297. https://doi.org/10.1016/s0165-6147(00)01716-8
Eich-Höchli, D., Oppliger, R., Golay, K. P., Baumann, P., & Eap, C. B. (2003). Methadone Maintenance Treatment and St. John’s Wort. Pharmacopsychiatry, 36(1), 35–37. https://doi.org/10.1055/s-2003-38090
Gaster, B., & Holroyd, J. (2000). St John’s Wort for Depression. Archives of Internal Medicine, 160(2), 152. https://doi.org/10.1001/archinte.160.2.152
Greeson, J. M., Sanford, B., & Monti, D. A. (2001). St. John’s wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology, 153(4), 402–414. https://doi.org/10.1007/s002130000625
Josey ES;Tackett RL. (2017). St. John’s wort: a new alternative for depression? International Journal of Clinical Pharmacology and Therapeutics, 37(3). https://pubmed.ncbi.nlm.nih.gov/10190758/
Kasper, S., Dienel, A., & Kieser, M. (2004). Continuation and long-term maintenance treatment with Hypericum extract WS® 5570 after successful acute treatment of mild to moderate depression – rationale and study design. International Journal of Methods in Psychiatric Research, 13(3), 176–183. https://doi.org/10.1002/mpr.173
Kholghi, G., Arjmandi-Rad, S., Zarrindast, M.-R., & Vaseghi, S. (2022). St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems? Naunyn-Schmiedeberg’s Archives of Pharmacology, 395(6). https://doi.org/10.1007/s00210-022-02229-z
Klemow, K. M., Bartlow, A., Crawford, J., Kocher, N., Shah, J., & Ritsick, M. (2014). Medical Attributes of St. John’s Wort (Hypericum perforatum). Nih.gov; CRC Press/Taylor & Francis. https://www.ncbi.nlm.nih.gov/books/NBK92750/#:~:text=Worldwide%20annual%20sales%20of%20products
Kupfer, D. J. (2005). The pharmacological management of depression. Dialogues in Clinical Neuroscience, 7(3), 191–205. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181740/
Lei, C., Li, N., Chen, J., & Wang, Q. (2023). Hypericin Ameliorates Depression-like Behaviors via Neurotrophin Signaling Pathway Mediating m6A Epitranscriptome Modification. Molecules, 28(9), 3859. https://doi.org/10.3390/molecules28093859
Li, J.-D., He, S.-L., Wang, G., Chen, J., Liu, X., Wang, T., Zhou, M., Du, C., Chen, H.-F., & Tian, W.-J. (2024). Filicinic acid based meroterpenoids from Hypericum elodeoides and their anti-Alzheimer’s disease effects. Bioorganic Chemistry, 107787–107787. https://doi.org/10.1016/j.bioorg.2024.107787
Maher, A. R., Hempel, S., Apaydin, E., Shanman, R. M., Booth, M., Miles, J. N. V., & Sorbero, M. E. (2016). St. John’s Wort for Major Depressive Disorder. Rand Health Quarterly, 5(4). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5158227/
Market, P. (2024). Herbal Supplements Market Size, Share & Report 2024-2032. Polaris. https://www.polarismarketresearch.com/industry-analysis/herbal-supplements-market
National Center for Complementary and Integrative Health. (2020). St. John’s wort. NCCIH. https://www.nccih.nih.gov/health/st-johns-wort
NCCIH. (2017, December). St. John’s Wort and Depression: In Depth. NCCIH. https://www.nccih.nih.gov/health/st-johns-wort-and-depression-in-depth
Ng, Q. X., Venkatanarayanan, N., & Ho, C. Y. X. (2017). Clinical use of Hypericum perforatum (St John’s wort) in depression: A meta-analysis. Journal of Affective Disorders, 210, 211–221. https://doi.org/10.1016/j.jad.2016.12.048
Nutrition, C. for F. S. and A. (2021, July 21). Blossom Nature, LLC - 612263 - 02/18/2021. FDA. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/blossom-nature-llc-612263-02182021
Oliveira, A. I., Pinho, C., Sarmento, B., & Dias, A. C. P. (2016). Neuroprotective Activity of Hypericum perforatum and Its Major Components. Frontiers in Plant Science, 7. https://doi.org/10.3389/fpls.2016.01004
Pannu, A., Sharma, P. C., Thakur, V. K., & Goyal, R. K. (2021). Emerging Role of Flavonoids as the Treatment of Depression. Biomolecules, 11(12), 1825. https://doi.org/10.3390/biom11121825
Peterson, B., & Nguyen, H. (2023, May 16). St. John’s Wort. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557465/
Raczkiewicz, I., Céline Rivière, Bouquet, P., Lowiese Desmarets, Tarricone, A., Camuzet, C., François, N., Lefèvre, G., Fabiola Silva Angulo, Robil, C., François Trottein, Sevser Sahpaz, Dubuisson, J., Sandrine Belouzard, Goffard, A., & Séron, K. (2024). Hyperforin, the major metabolite of St. John’s wort, exhibits pan-coronavirus antiviral activity. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1443183
Saller, R., Melzer, J., & Reichling, J. (2003). Johanniskraut (Hypericum perforatum): Ein plurivalenter Rohstoff für traditionelle und moderne Therapien. Complementary Medicine Research, 10(1), 33–40. https://doi.org/10.1159/000071690
Saller, R., & Rostock, M. (2012). Multimorbidität und Multi-Target-Therapie in der Phytotherapie. Praxis, 101(25), 1637–1642. https://doi.org/10.1024/1661-8157/a001149
Shelton, R. C. (2009). St John’s Wort (Hypericum perforatum) in Major Depression. The Journal of Clinical Psychiatry, 70(suppl 5), 23–27. https://doi.org/10.4088/jcp.8157su1c.05
Singer, A., Wonnemann, M., & Müller, W. E. (1999). Hyperforin, a major antidepressant constituent of St. John’s Wort, inhibits serotonin uptake by elevating free intracellular Na+1. The Journal of Pharmacology and Experimental Therapeutics, 290(3), 1363–1368. https://pubmed.ncbi.nlm.nih.gov/10454515/
St. John’s Wort Extract Market, Report Size, Worth, Revenue, Growth, Industry Value, Share 2024. (2024). Valuates Reports. https://reports.valuates.com/market-reports/QYRE-Auto-19T9546/global-st-john-s-wort-extract
St. John’s Wort (Hypericum perforatum) - Search Results - PubMed. (2014). PubMed. https://pubmed.ncbi.nlm.nih.gov/?term=St.+John%27s+Wort+%28Hypericum+perforatum%29&size=200
World Health Organization. (2023, March 31). Depressive disorder (depression). World Health Organization. https://www.who.int/news-room/fact-sheets/detail/depression
Wu, S., & Tatsis, E. C. (2024). Specialized metabolism in St John’s wort. Current Opinion in Plant Biology, 82, 102625–102625. https://doi.org/10.1016/j.pbi.2024.102625
View Dimensions
View Altmetric
Save
Citation
View
Share